Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABEO
DateTimeSourceHeadlineSymbolCompany
10/18/20188:03AMGlobeNewswire Inc.Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical OfficerNASDAQ:ABEOAbeona Therapeutics Inc
10/09/20184:42PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ABEOAbeona Therapeutics Inc
10/05/20186:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
09/28/20188:45AMGlobeNewswire Inc.Abeona Announces Participation at Upcoming ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
09/12/201811:51PMGlobeNewswire Inc.Abeona Therapeutics gibt Genehmigung für den Beginn einer klinischen Phase-I/II-Gentherapie-Studie für Patienten mit MPS II...NASDAQ:ABEOAbeona Therapeutics Inc
09/12/201811:51PMGlobeNewswire Inc.Abeona Therapeutics annonce l'autorisation de commencer l'étude clinique de phase 1/2 sur la thérapie génique pour les pat...NASDAQ:ABEOAbeona Therapeutics Inc
09/12/20188:45AMGlobeNewswire Inc.Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in S...NASDAQ:ABEOAbeona Therapeutics Inc
09/12/20188:45AMGlobeNewswire Inc.Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in S...NASDAQ:ABEOAbeona Therapeutics Inc
09/04/20188:45AMGlobeNewswire Inc.Abeona Announces Participation at Upcoming ConferencesNASDAQ:ABEOAbeona Therapeutics Inc
08/20/20186:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
08/17/20185:23PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ABEOAbeona Therapeutics Inc
08/16/20185:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
08/09/20184:40PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
08/09/20184:20PMGlobeNewswire Inc.Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business HighlightsNASDAQ:ABEOAbeona Therapeutics Inc
08/09/20184:09PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABEOAbeona Therapeutics Inc
07/30/20185:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
07/26/20188:30AMGlobeNewswire Inc.Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial OfficerNASDAQ:ABEOAbeona Therapeutics Inc
06/18/20184:21PMBusiness WireNewman Ferrara LLP Announces Corporate Governance Investigation of Abeona Therapeutics Inc. – ABEONASDAQ:ABEOAbeona Therapeutics Inc
06/08/20186:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ABEOAbeona Therapeutics Inc
06/06/20188:45AMGlobeNewswire Inc.Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare ConferenceNASDAQ:ABEOAbeona Therapeutics Inc
06/01/20184:19PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ABEOAbeona Therapeutics Inc
05/31/20188:45AMGlobeNewswire Inc.Abeona Therapeutics Announces Opening of Commercial Gene & Cell Therapy Manufacturing Facility in OhioNASDAQ:ABEOAbeona Therapeutics Inc
05/23/20187:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABEOAbeona Therapeutics Inc
05/23/20187:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABEOAbeona Therapeutics Inc
05/21/20186:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABEOAbeona Therapeutics Inc
05/21/20186:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABEOAbeona Therapeutics Inc
05/18/20189:25AMGlobeNewswire Inc.Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT MeetingNASDAQ:ABEOAbeona Therapeutics Inc
05/17/20189:20AMGlobeNewswire Inc.Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT MeetingNASDAQ:ABEOAbeona Therapeutics Inc
05/14/20185:23PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ABEOAbeona Therapeutics Inc
05/14/20188:15AMGlobeNewswire Inc.Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of DirectorsNASDAQ:ABEOAbeona Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ABEO

Your Recent History

Delayed Upgrade Clock